Cryoglobulinism is a blood disorder when the blood contains large amounts of cryoglobulins (abnormal proteins) that become insoluble at low temperatures. In contrast, cold agglutinins cause agglutination of red blood cells. Cryoglobulins usually precipitate below normal body temperature (37°C) and resolubilize upon heating.
In some asymptomatic individuals, cryoglobulins may be temporarily present, often in association with certain infections. However, in patients with cryoglobulinemia, deposits of these proteins may seal blood vessels and lead to limb necrosis. Such a transition can begin as asymptomatic and progress to serious health problems.
Cryoglobulinemias are often associated with various pre-malignant, malignant, infectious or autoimmune diseases and should always be taken seriously.
According to the Brouet classification, cryoglobulinemias are divided into three main types, which are classified according to the associated immunoglobulin class and other associated diseases. These three types include:
The clinical features of cryoglobulinemia reflect the damage caused by cryoglobulin to tissues. This damage can occur through a variety of mechanisms, such as increasing blood viscosity and causing thrombosis of small blood vessels. These can cause the following symptoms:
Symptoms of cryoglobulinemia may vary depending on the underlying blood disorder, infectious disease, or autoimmune syndrome.
Cryoglobulins are composed of one or more components, such as monoclonal or polyclonal IgM, IgG, and IgA antibodies. The different components often reflect the underlying disorders associated with these diseases. For example, monoclonal IgM is found in Waldenström's macroglobulinemia, or immunoglobulins that mutate in amounts in acute infectious cases.
Diagnosis of cryoglobulinemia usually requires a variety of tests to differentiate between related diseases. This involves immunoelectrophoresis and immunofixation of cryoglobulin-bearing sera to determine the presence and type of immunoglobulins. This is key in assessing symptoms of cryoglobulinemia.
Patients with cryoglobulinemia should avoid low temperature environments when symptoms occur and should protect their distal limbs from the cold. Further evaluation of candidates for asymptomatic cryoglobulinemia can help determine whether treatment is needed. In some cases, such as acutely ill patients, emergency treatments such as plasma exchange or dialysis may be required.
Treatment generally targets the underlying cause, such as "cryoglobulin"-related malignant diseases or autoimmune diseases.
The transformation process of cryoglobulinemia is undoubtedly an important area of diagnosis and treatment. This change from asymptomatic to potentially dangerous is thought-provoking. In the current medical environment, are we paying enough attention to the early prevention and detection of this disease, rather than just treating its consequences?